1Revollo JR, Korner A, Mills KF, et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta ceils as a systemic NAD biosynthetic enzyme [J]. Cell Metab,2007;6(5) :363-75.
2Haigis MC, Guarente LP. Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction[J]. Genes Dev,2006 ;20(21 ) :2913-21.
3McGlothlin JR, Gao L, Lavoie T,et al. Molecular cloning and characterization of canine pre-B-cellcolony-enhancing factor[J]. Biochem Genet, 2005 ;43(34) :127-41.
4de Luis DA, Gonzalez Sagrado M, Conde R,et al. Effect of a hypocalorlc diet on serum visfatin in obese non-diabetic patients[J]. Nutrition ,2008 ; 24(6) :517-21.
5Matsuzawa Y. Therapy insight :adipocytokines in metabolic syndrome and related cardiovascular disease [J].Nature Clinical Practice Cardiovasc Med ,2006 ;3 ( 1 ) :35-42.
6Lin CC, Lai MM, Li TC ,et al. Relationship between serum retinol-binding protein 4 and visfatin and the metabolic syndrome [J]. Diabetes Res Clin Prac ,2009 ;85( 1 ) :24-9.
7Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus[J]. J Clin Endocrinol Metab ,2006 ;91 ( 1 ) :295-300.
8Klfiting N, Kloting I. Visfatin:gene expression in isolated adipoeytes and sequence analysis in obese WOKW rats compared with lean control rats [J]. Biochemi Biophys Res Commun,2005 ;332(4) :1070-2.
9Korner A, BOttcher Y, Enigk B, et al. Effect of genetic variation in the visfatin gene(PBEF1 ) on obesity, glucose metabolism, and blood pres- sure in children [J]. Metabolism Exp ,2007;56 (6) :772-7.
10Licata G, Scaglione R, Ganguzza A ,et al. Central obesity and hyperten- sion. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects [J]. Am J Hypertens, 1994;7 (4) :314-20.
7K. G. M. M. Alberti. The metabolic syndrome - a new worldwide definition [ J ]. Diabetic Medicine,2005,23 ( 5 ) : 469 - 480.
8Bergman RN, Kim SP, Hsu. IR, et al. Abdominal obesity : role in the. pathophysiology of metabolic disease and cardiovascular risk [ J]. Am J Med, 2007, 120(2Supp|l) : $3 -8.
9Susan EW, Laura LG, Mitchell SW. Adipose tissue: The new endocrine organ? A review article[ J~. Dig Dis Sci ,2009, 54 (9) :1847 - 1857.
